Our findings demonstrated that ULBP2 expressed on the surface of cancer cells promoted tumor growth by suppressing NK cell function, suggesting that modulating ULBP2-NKG2D interactions could be a potential target for cancer therapy. The gene discussed is KLRK1; the disease is neoplasm.